GSK press releases Follow GSK presents positive data for B7-H4-targeted ADC in gynaecological cancers Promising efficacy and safety profile supports start of five pivotal phase III trials in 2026. https://www.gsk.com/en-gb/media/press-releases/gsk-presents-positive-data-for-b7-h4-targeted-adc-in-gynaecological-cancers/ gsk.com
